News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Register now to delve into breast cancer knowledge – ESMO
Photo from ESMO/LinkedIn
Jun 21, 2024, 07:49

Register now to delve into breast cancer knowledge – ESMO

The European Society for Medical Oncology (ESMO) shared a post on X:

“Enhance your ESMO membership! Register now to delve into breast cancer knowledge and engage with experts in real-time. Don’t miss out on staying informed and connected.

Register now!”

Source: ESMO/X

Breast Cancer cancer ESMO ESMO membership OncoDaily Oncology
Special Coverage
Blog
Jan 29, 2025, 22:39
Join SIOP for 'Radiotherapy for Rhabdomyosarcoma' on Paediatric Radiation Oncology Series
Blog
Jan 29, 2025, 22:27
Pembrolizumab and chemotherapy in high-risk, early-stage, ER+/HER2− breast cancer
Blog
Jan 29, 2025, 22:27
CtDNA in CRC Surveillance - Ready for Prime Time?
Insight
Jan 29, 2025, 22:27
The causes and consequences of clonal hematopoiesis after stem cell transplantation
Blog
Jan 29, 2025, 22:26
Julie S. Torode: Discussing new data to support advocacy on access to quality radiotherapy in Africa
Blog
Jan 29, 2025, 22:26
Denis Horgan: Precision Oncology - A Global Perspective on Implementation and Policy Development
Blog
Jan 29, 2025, 22:26
Monica Bertagnolli: Confident and healthy because of the results of many decades of NIH-funded research
Blog
Jan 29, 2025, 22:26
Mandi Pratt-Chapman: GW Oncology Patient Navigation - The Fundamentals Update
Blog
Jan 29, 2025, 22:26
Egyptian Society Of Breast Imaging - Highlights from BGICC2025
Blog
Jan 29, 2025, 22:26
Integrative Oncology Working Group - The Power of Words: Using Language as a Therapeutic Tool
Blog
Jan 29, 2025, 22:14
Yüksel Ürün: The impact of comorbidities on survival in cancer patients receiving ICIs
Blog
Jan 29, 2025, 22:05
Preliminary Safety, Antitumor Activity, and ctDNA Changes with Zoldonrasib in KRAS G12D PDAC